Mismatch Repair
Mismatch Repair is a critical DNA repair mechanism that corrects errors during replication, ensuring genomic stability and preventing mutations linked to cancer.
Mismatch Repair (MMR) is the DNA repair pathway responsible for correcting base-base mismatches and small insertion/deletion loops that escape the proofreading activity of replicative DNA polymerases, acting immediately following DNA replication to detect and correct these errors using the parental (template) strand as the reference for what the correct sequence should be. It is distinct from base excision repair and nucleotide excision repair in that its substrates are not chemically damaged bases but rather correctly formed bases that are simply mispaired or misaligned as a consequence of imperfect replication fidelity.
The Errors MMR Corrects
Base-Base Mismatches
Despite the high intrinsic fidelity of replicative DNA polymerases and their built-in proofreading exonuclease activity, a small residual rate of base misincorporation still occurs during genome replication, producing mismatches — most commonly involving a normal, undamaged base paired incorrectly with its template partner — that MMR is responsible for detecting and correcting before they become permanently fixed as mutations in the next round of replication.
Insertion/Deletion Loops
As discussed under microsatellite instability, DNA polymerase slippage at repetitive sequence is particularly prone to generating small insertion or deletion loops, in which one strand transiently loops out relative to its complement — MMR's correction of these loops at repetitive loci is what maintains stable microsatellite repeat lengths across cell divisions in MMR-proficient cells.
Core Components and Mechanism
Mismatch Recognition by MutS Homologs
In humans, mismatch recognition is carried out by heterodimeric complexes of MutS homolog proteins: MSH2 paired with MSH6 (forming MutSα) preferentially recognizes single base-base mismatches and small insertion/deletion loops, while MSH2 paired with MSH3 (forming MutSβ) preferentially recognizes larger insertion/deletion loops, giving the recognition step a degree of substrate specialization across these two partially overlapping complexes.
Recruitment of MutL Homologs
Following mismatch recognition, MutL homolog complexes — principally MLH1 paired with PMS2 (forming MutLα) — are recruited to the site, coordinating the downstream steps of strand discrimination, excision, and resynthesis, and functioning as the central coordinating hub of the pathway analogous to the scaffold role XRCC1 plays in base excision repair.
Strand Discrimination
A critical requirement of MMR is correctly identifying which of the two strands is the newly synthesized (and therefore error-containing) strand, as opposed to the parental template strand that reflects the correct sequence — in humans this discrimination is thought to rely substantially on features associated with ongoing replication, including strand discontinuities and PCNA's asymmetric loading orientation on the newly synthesized strand, allowing the repair machinery to excise and correct the error-containing strand specifically rather than risk fixing the mismatch into the wrong, originally correct strand.
Excision and Resynthesis
Once the incorrect strand is identified, an exonuclease (principally EXO1) degrades the DNA from a nearby strand discontinuity through and past the mismatch, after which DNA polymerase δ resynthesizes the excised region using the intact parental strand as template, and DNA ligase seals the remaining nick to complete the repair.
MMR's Coupling to DNA Replication
Temporal and Physical Proximity to the Replication Fork
MMR operates in close temporal and physical association with ongoing DNA replication, reflecting that its substrates — replication errors — are generated specifically during that process and are most efficiently corrected while replication-associated strand discrimination cues are still available, rather than being detectable or correctable at some arbitrary later point in the cell cycle.
Interaction With PCNA and the Replication Machinery
MutSα and MutLα both interact directly with PCNA, the replication processivity clamp, physically linking mismatch surveillance to the replication machinery itself and helping explain both how MMR achieves efficient strand discrimination and how it is positioned to act promptly on replication errors as they arise.
Consequences of MMR Deficiency
Elevated Genome-Wide Mutation Rate
Loss of MMR function, through inherited germline mutation (as in Lynch syndrome) or somatic inactivation (most commonly MLH1 promoter hypermethylation), produces a dramatically elevated genome-wide point mutation and small insertion/deletion rate, since replication errors that would normally be corrected are instead permanently fixed into the genome at the next round of replication.
Microsatellite Instability as the Signature Consequence
The specific, readily detectable consequence of MMR deficiency at repetitive microsatellite sequences — covered in detail under microsatellite instability — arises because these sequences are disproportionately prone to generating the insertion/deletion loops that MMR would normally correct, making microsatellite length drift a sensitive and widely used clinical indicator of underlying MMR pathway dysfunction.
MMR's Broader Role Beyond Simple Repair
Involvement in Damage Signaling
Beyond its direct repair function, the MMR machinery participates in signaling certain types of DNA damage to downstream checkpoint and apoptotic pathways, meaning MMR-proficient cells exposed to specific DNA-damaging agents can trigger cell death responses that MMR-deficient cells, lacking this signaling function alongside their repair defect, may fail to mount — a consideration relevant to how MMR status influences chemotherapy sensitivity for certain DNA-damaging agents.
Clinical and Research Relevance
A Direct Driver of Cancer Predisposition and Tumor Biology
MMR deficiency's role in both hereditary cancer predisposition (Lynch syndrome) and sporadic tumor development, along with its status as one of the most clinically actionable biomarkers guiding immunotherapy selection due to the high mutational burden and consequent neoantigen load it produces, makes MMR pathway status among the most clinically consequential DNA repair assessments in modern oncology, connecting a fundamental replication-fidelity mechanism directly to real-world treatment decisions.
Practical Significance
Mismatch Repair maintains replication fidelity by detecting and correcting base-base mismatches and insertion/deletion loops that escape polymerase proofreading, through a coordinated process of MutS homolog-mediated recognition, MutL homolog-coordinated strand discrimination, and exonuclease-mediated excision and resynthesis operating in close association with the replication machinery itself. Its deficiency, whether inherited or acquired, produces a distinctive hypermutator phenotype with direct consequences for cancer predisposition, tumor mutational burden, and — through the resulting elevated neoantigen load — response to immune checkpoint inhibitor therapy.